William D. Schwieterman, Chief Medical Officer at Chelsea Therapeutics International, Ltd. (CHTP), bought 45,141 shares at $4.46 ($201K) on 2011-11-23, disclosed to the SEC on 2011-11-28.
Open-market purchase of $201k CHTP by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |